Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

An Alternative Approach to Breast Health
  • USA - English


News provided by

Claxton-Hepburn Medical Center

Feb 14, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Ogdensburg, NY (PRWEB) February 14, 2014 -- Radiation therapy, a popular, safe method for eradicating cancer cells that may be still be present after surgery, plays an important role in treating all stages of breast cancer. Traditional radiation therapy uses high-energy rays or particles to destroy cancer cells and is typically administered beginning four weeks after a lumpectomy for early-stage breast cancer.

“We are treating breast cancer the most proactive way possible. Breast conservation—minimal surgery in conjunction with radiation—is just as effective as more invasive surgeries.” — John Gebert, MD, radiation oncologist, Richard E. Winter Cancer Center

Post this

Today, a quicker, more powerful way to deliver radiation therapy, known as accelerated partial breast irradiation (APBI), is fast becoming a popular alternative among oncologists. During treatments, radiation is delivered to only part of the breast over five days.

“Claxton-Hepburn is passionately committed to obtaining and utilizing the most advanced equipment available that will deliver the most precise dose of radiation possible,” explains John W. Gebert, MD, radiation oncologist at the Richard E. Winter Cancer Center at Claxton-Hepburn Medical Center. “Our goal is to destroy the cancer entirely, while preserving as much breast tissue as we can.”

Focusing on the Now

There are two approaches to administering APBI. Breast brachytherapy is an internal form of radiation that requires the placement of a radioactive “seed” near the affected site in an effort to kill any undetected cancer cells that remain after surgery.

While there are several methods for the radiation to reach the site, one of the more common procedures utilizes a specialized catheter or balloon inserted into the breast tissue. The catheter holds the seed in a targeted area immediately surrounding the lumpectomy site. The device remains in place during the course of APBI treatment, which lasts an average of five days.

External beam radiation treats part of the breast; however, treatment is delivered using the linear accelerator and offers shorter treatment times and can usually be completed in one week. The linear accelerator delivers high-energy X-rays to the exact region of the patient’s tumor. These treatments can be designed in such a way that they destroy the cancer cells while sparing the surrounding normal tissue. It is a preferable method of treatment that minimizes radiation. The precision of the radiation dose is equivalent to approximately half the thickness of a dime.

“The linear accelerator blocks the radiation field from damaging the surrounding healthy tissue with unnecessary exposure,” says Doug Salhani, PhD, FCCPM, board-certified medical physicist at Claxton-Hepburn who works with physicians in planning radiation treatments for cancer patients. “It is highly effective in delivering radiation therapy to odd or irregularly shaped tumors, and is especially beneficial for treating tumors that may be close to or surrounding vital organs that were previously considered untreatable.”

Every Step of the Way

Dedicated to providing comprehensive care for newly diagnosed patients with breast cancer, the specialized team at the Breast Health Center at Claxton-Hepburn Medical Center is here to help at every stage of the planning process. Each patient meets one on one with her surgeon, radiation oncologist, medical oncologist, and patient navigator, who help guide her through her decision-making to reduce stress and anxiety. While scheduling radiation treatments around work and family can be challenging for some women, the staff at the Breast Health Center at Claxton-Hepburn work individually with each patient to keep appointments as short as possible. “The typical course of treatment with traditional whole breast radiation therapy requires women to come in for radiation sessions over a period of six weeks. That kind of treatment schedule can be difficult for a busy woman to manage,” Dr. Gebert says. “APBI can be a more convenient and practical treatment option because it is a single week in duration, allowing many women to continue their normal activities while undergoing radiation.”

By partnering with the Richard E. Winter Cancer Center, the Breast Health Center offers patients the most modern diagnostic imaging and treatment tools available. Services in addition to APBI include: biopsy, breast-conserving lumpectomy, chemotherapy, CT, PET/CT, MRI, mammography, and mastectomy.

“We want all of our patients to be confident that they are being cared for at a cancer center with the highest level of experience in the region,” Dr. Gebert says. “The well-being of our patients is at the forefront of everything we do.”

For more information about the oncology services and breast cancer treatment options offered at Claxton-Hepburn’s Breast Health Center, visit http://www.claxtonhepburn.org and click “Services” and “Breast Health.”

Laura Shea, Claxton-Hepburn Medical Center, http://www.claxtonhepburn.org, +1 (315) 713-5249, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.